Neoplasms
Conditions
Interventions
This is a controlled, one-arm, double-blind, pilot clinical study. Twenty healthy volunteers, men and women, aged 20 to 35 years, with no history of skin disease or skin cancer participated in the stu
Sponsors
Universidade Federal de Sergipe
Universidade Federal de Sergipe
Eligibility
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Healthy individuals;individuals aged 20-35 years;individuals with no history of dermatological disease;both sexes.
Exclusion criteria
Exclusion criteria: Individuals with skin lesions in the forearm area;individuals under 20 years of age or over 35 years of age;individuals with allergies to the components of the formulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to obtain low levels of erythema, melanin and transepidermal water loss in the forearm areas of the 20 volunteers to whom the test formulation (dried hesperetin nanocapsules with titanium dioxide) and the commercial sunscreen were applied. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that no erythema will form in the area treated with the test formulation after 3 days of UVA-UVB irradiation. | — |
Countries
Brazil
Contacts
Public ContactJose Adao Nascimento Júnior
Universidade Federal de Sergipe
Outcome results
None listed